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Background/aim: Knowledge regarding pain relief during labor remains insufficient. We aimed to determine and compare the
effectiveness and safety of epidural analgesia, combined spinal–epidural analgesia, and parenteral meperidine on both mothers and
fetuses.
Materials and methods: This study was designed as an observational case-control study. We collected prospective data from patients
whose labor pain management was conducted with meperidine in addition to retrospective cohort data of neuraxial methods; 138
patients were enrolled. Epidural analgesia group consisted of 68 patients, whereas combined spinal-epidural (CSE) analgesia group and
meperidine group consisted of 50 and 20 patients, respectively. We compared the delivery patterns, labor durations, pain levels, side
effects, maternal satisfaction levels, and neonatal outcomes of the various pain management methods.
Results: Patient demographics, duration of first, second, and third labor stages, and instrumental delivery rates were comparable among
groups (P > 0.05). Cesarean section tended to be less frequent in the CSE group. In the meperidine group, visual analog scale (VAS)
values and sedation were significantly higher (P < 0.001) and maternal satisfaction lower (P < 0.001). Hypotension tended to be more
frequent in the meperidine group. APGAR scores at the 1st and 5th min were similar among the groups and between meperidine
subgroups defined by three different administration times (<1 h, 1‒4 h, ≥4 h; P > 0.05).
Conclusion: Neuraxial methods had no effect on instrumental delivery rates. CSE represented a near significant risk reduction in
cesarean section. Our results demonstrated that regional analgesia methods were reasonably safe for both mother and fetus, and regional
analgesia methods resulted in greater maternal satisfaction and pain control compared to meperidine.
Key words: Labor pain, meperidine, neuraxial analgesia

1. Introduction
Labor pain is one of the most painful experiences
for most women. It alters respiratory, cardiovascular,
neuroendocrine, and limbic systems and may lead to
adverse outcomes as a result. In addition, it triggers
psychodynamic behaviors resulting in stress and anxiety
[1], which might cause metabolic acidosis and decreased
uteroplacental blood flow [2]. Achieving sufficient pain
relief is a significant factor for successful labor and
maternal satisfaction.
Numerous pharmacological and nonpharmacological
methods are currently being used to reduce labor
pain [3]. The choice of analgesic method depends on
the expectations of the mother, the joint decision of
anesthesiology and reanimation and the obstetrics clinics,
and the progress of labor [4]. Neuraxial methods provide
almost perfect pain control when the mother is fully awake
and cooperative [5]. The side effects of these methods on
the maternal cardiovascular-pulmonary system and fetal

physiology are considered minimal [6]. However, there
is conflicting information regarding the issue. There are
studies reporting that neuroaxial analgesia significantly
increases the cesarean rate [7,8], whereas some studies
reported the contrary [9,10]. Furthermore, controversies
remain regarding the risk of instrumental delivery.
Instrumental deliveries are associated with various longterm disadvantages, including an increased likelihood
of fecal incontinence, sexual dysfunction, and hospital
stay extensions [11–13]. Recent trials have reported the
lowered risk of instrumental delivery with modern lowdose epidural regimens; however, these regimens do not
completely mitigate these adverse outcomes.
Systemic analgesics may be used for pain relief in labor.
The commonest opioid used for labor is meperidine [14],
administered by intramuscular (im) injection. Meperidine
remains the standard of care for labor pain in some clinics;
it can also be used at the request of the patient or in cases
when neuraxial analgesia is not feasible. However, current
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knowledge remains uncertain. Some studies have reported
an increase in the frequency of the neonatal depression
when delivery occurred after 2‒3 h after meperidine
administration [15] while some studies have not [16,17].
Furthermore, there is a gap of knowledge in terms of
maternal satisfaction with meperidine treatment [18].
In 2018, a Cochrane review assessed the effectiveness
and safety of all types of epidural analgesia on mothers and
infants compared to nonepidural methods. They reported
the superior efficacy of epidural analgesia in reducing pain
and improving maternal satisfaction. In addition, they
reported that studies regarding this topic provided lowquality evidence, limited by inconsistency and imprecision
and underlined the need for more robust research to
evaluate possible maternal and fetal effects, in particular,
side effects and maternal satisfaction[18].
In view of the controversies and knowledge gap existing
in the literature, we aimed to determine the effectiveness
and safety of epidural analgesia, combined spinal–epidural
analgesia, and parenteral meperidine on both the mother
and fetus.
2. Materials and methods
2.1. Patient selection, inclusion, and exclusion criteria
This study was designed as a case-control study. Informed
consent was obtained from patients. This study was
approved by the ethical committee of Hacettepe University
(Date: 24/06/2015- Number: 16969557-721 NO: GO
15/376-15). After the approval of the local ethic committee,
the files of patients who had regional analgesia for labor
pain were analyzed retrospectively. Among 167 cases, 49
cases were excluded due to missing data (n = 35), gestation
week lower than 37 weeks or higher than 41 weeks (n = 4
and n = 1, respectively), catheter problems (extraction of
the catheter due to complication, n = 3; catheter dislocation
n = 1), and spinal anesthesia (n = 5). Eventually, the
retrospective arm comprised 118 patients, including 68
patients who were administered with epidurals and 50
patients with CSE analgesia. In addition to the retrospective
cohort data, we collected the prospective data of patients
whose labor pain management was done with meperidine.
Twenty patients who were unwilling to have neuraxial
analgesia and given instead meperidine according to the
standard protocol were included in the study. Patients who
were in gestational periods less than 37 or higher than 41
gestational weeks were excluded in addition to those with
fetal presentation and multiple pregnancies.
2.2. Data collection
We have applied a standard labor pain protocol in our
clinic since 2012. In accordance with this protocol, we
meticulously recorded data from all patients, including
the following:

· demographic data (age, height, weight, number of
births, gestational age, and presence of comorbid diseases);
· intervention information (local anesthetic agent,
opioid solution content, application technique, and
administration method [infusion/bolus/infusion and
bolus]);
· complications, presence, and duration of motorsensorial block;
· cervical dilatation and contraction rate at the moment
of catheter insertion, durations of the Stages 1, 2, and 3;
· amount of drug used during infusion, bolus amount,
other drug use, the number of bolus need;
· hemodynamic data (pulse, systolic and diastolic
arterial pressure, and fetal heart rate after 5, 10, 15, 30, 45,
60, 90 min, and every following half hour);
· delivery patterns (vaginal/cesarean section), usage of
vacuum or forceps, indication for cesarean section, if there
is any;
· general pain evaluations (visual analogue scale [VAS]
scores prior to application, 15th min, first and second
stage, at the time of episiotomy, and fetal expulsion);
· maternal satisfaction levels (based on a 5-point Likert
scale);
· newborn outcomes (weight, first and 5th min Apgar
scores, intensive care unit [ICU] admission, and reasons
for admission to ICU).
2.3. Standardized application methods
For the CSE technique, 15‒25 µg of fentanyl with 2.5 mg
bupivacaine was used for spinal analgesia. Continuous
infusion was started half an hour after the spinal application.
In the pure epidural technique, bolus 0.125%‒0.25%
bupivacaine (10 mL) was given after the test. In both
methods, after the block placement, patient-controlled
analgesia (PCA) with baseline infusion followed. The
baseline rate was set to 8‒12 mL/h, the bolus to 5 mL, the
lock duration to 10 min, the hourly limit to 30 min with a
solution of 1%‒2% µg/fentanyl and 0.0625% bupivacaine.
We considered birth a natural process. If patients
demanded pain control, we offered neuraxial analgesia
as the standard treatment for labor pain. Patients who
did not want neuraxial analgesia and those administered
meperidine for labor pain were enrolled as the prospective
observational group; 25 mg intravenous (IV) and 50 mg
intramuscular (IM) meperidine were administered to
these patients, respectively. Aforementioned variables,
with the exception of the intervention and regional
block information, were also recorded for those patients
administered meperidine.
2.4. Statistical methods
The data were analyzed with SPSS 21.0 for Windows. We
examined the suitability of the numerical variables to
normal distribution using visual (histogram and probability
graphs) and analytical methods (the Kolmogorov–
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Smirnov/Shapiro–Wilk tests). We made comparisons of
numerical data between groups using analysis of variance
(ANOVA) or Kruskal–Wallis (where appropriate). A 5%
type I error level was used to infer statistical significance.
Further pairwise comparisons were analyzed with post hoc
Tukey test or Mann–Whitney U-tests using Bonferroni
correction and setting the statistical significance at 1.67%
type I error level (where appropriate). p1 represents
hypothesis between the epidural and CSE groups; p2,
between CSE and meperidine group; and p3, between the
epidural and meperidine groups. We compared nominal
data with Chi-square or Fisher’s test. We presented
descriptive analyses as mean ± standard deviation (s.d.)
or median (minimum and maximum) values according
to distribution. Exceptional cases were specified on the
tables. The minimum number of participants required
was determined using power analysis. In order to detect
a minimum clinically significant difference of one-unit
change on the satisfaction scale with a statistical power at
the 80% level and 5% type-1 error, we selected a minimum
of 20 patients for meperidine treatment and at least 50
participants for each of the other two groups.
3. Results
Table 1 details the demographic and clinical characteristics
of the patients. Epidural treatment included 68 patients,
CSE treatment included 50 patients, and the meperidine
group included 20 patients. The mean age of the patients
was 27.3 ± 4.9 years, and the mean gestational age was
39 ± 1.0. Age, body mass index (BMI), gestational age,
nulliparity, ASA classification, and cervical dilatation at
the time of catheter insertion were comparable between
the groups. No significant difference between drugs’ doses
(infusion/bolus/infusion+bolus) in epidural and CSE
groups (P > 0.05) were detected.
Table 2 outlines labor and delivery characteristics. One
hundred patients (72.5%) delivered their infant via normal

vaginal delivery, and 38 (27.5%) ended up with cesarean
sections. The duration of the vaginal delivery stages was
similar between groups (P > 0.05). Instrumental delivery
was used only for one patient in the epidural group (P =
0.55). There was a trend towards to decrease of risk in the
cesarean delivery rate in the CSE group (p1 = 0.04, p2 =
0.06, and p3 = 0.52).
Among patients who were applied neuraxial
methods, those who gave birth through vaginal delivery
were divided into two groups according to the width of
cervical dilatation at the time of catheter insertion: <4 cm
(n = 45) and ≥4 cm (n = 42). There was no statistically
significant difference among the groups regarding the
proportion of the nulliparity (P = 0.76). The duration of
the first stage was 12 h (min–max, 2.5‒28.5) in patients
with cervical dilatation measuring <4 cm at the time of
catheter insertion, 7.25 h (min–max, 1.5‒36) in patients
with cervical dilatation measuring ≥4 cm. The duration
of the first stage was significantly longer in the group
with cervical dilatation measuring <4cm (P = 0.012). The
duration of the second stage was similar (10 min, 2‒30; 7
min, 5‒20, respectively; P = 0.123).
Cesarean section was performed due to deceleration in
the nonstress test (NST) (n = 21), arrest of labor (n = 13),
patients own will (n = 1), an unknown indication (n = 2),
and uterine tetany (n = 1). The cesarean section rates due
to deceleration or arrest of labor were comparable between
groups (P > 0.05). Maternal satisfaction and VAS values at
the 15th min, first stage, second stage, time of episiotomy,
and time of pushing were differed between groups (P <
0.001). Pairwise comparisons demonstrated that VAS
values in the meperidine group were significantly higher,
whereas maternal satisfaction was lower (P < 0.001)
(Figure).
Table 3 details the motor block and side effects of the
various methods. Motor block and pruritus was comparable
between groups (P = 0.28 and P = 0.81, respectively).

Table 1. Patient characteristics stratified by analgesic methods.

Age (y)x

Total
(n = 138)

Epidural
(n = 68)

CSE
(n = 50)

Meperidine
(n = 20)

P-value

27.3 (4.9)

27.2 (4.4)

27.3 (5.5)

27.5 (4.8)

0.97

BMI (kg/m )

28.4 (3.7)

28.2 (4.0)

29.2 (3.2)

27.5 (3.6)

0.23

Gestational age (wk) x

39 (1.0)

39 (1.0)

392 (1.2)

39 (1.1)

0.74

Nulliparity (%)

58

57

56

65

0.78

ASA I/II/III

122/12/4

62/4/2

45/5/0

15/3/2

0.11

Cervical dilatation at catheter insertion (cm) *

3 (0–6)

3 (0–6)

3 (2–5)

3 (1–6)

0.14

Need for cesarean section

38 (28%)

22 (32%)

8 (16%)

8 (40%)

0.06

2 x

Data represented as mean (SD), *Data represented as median (min–max) BMI = Body mass index, CSE = Combined spinal epidural,
ASA=American Society of Anesthesiologists.
x
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Table 2. Labor and delivery characteristics of patients.
Epidural

CSE

Meperidine

n = 46

n = 42

n = 12

Duration of first stage, h

11.5 (2.5-102)

9 (1.5-24.5)

6.75(3-22.5)

0.22

Duration of second stage, min

9(2–20)

10(5–30)

10(2–15)

0.57

Duration of third stage, min

5(2–15)

5(2–20)

8.5(2–11)

0.12

Vacuum-forceps usage

1 (2.2%)

-

-

0.55

Normal spontaneous vaginal delivery (n=100)

P-value

n = 22

n=8

n=8

Deceleration (n = 21)

11(50%)

6(75%)

4(50%)

0.55

Arrest of labor (n = 13)

8(36%)

2(25%)

3(38%)

0.91

Uterine tetany (n = 1)

1(5%)

-

-

Patient’s own will (n = 1)

-

-

1(12%)

Cesarean delivery (n = 38)*

*Missing data, the indication of caesarean section could not be reached from files of two patients. CSE; Combined spinal epidural
10

Epidural

9

CSE

Meperidine

8
7
6
5
4
3
2
1
0

VAS, baseline

VAS, 15. min. VAS, First stage VAS, Second stage Maternal satisfaction

Figure. VAS values of the groups at different time points.
Table 3. Comparison of motor block and adverse events between groups.
Epidural
n = 68

CSE
n = 50

Meperidine
n = 20

P-value

Motor block

17(25%)

8(16%)

-

-

Pruritus

1(1.5%)

1(2%)

-

0.81

Sedation

-

-

6(30%)

<0.001

Nausea

4(5.9%)

2(4%)

3(15%)

0.23

Vomiting

2(2.9%)

3(6%)

1(5%)

0.79

Hypotension

15(22.1%)

10(20%)

-

0.07

Ephedrine use

13 (19%)

7 (14%)

-

0.18

Shivering

2(2.9%)

-

-

0.35

Back pain

2(2.9%)

2(4%)

-

0.67

CSE; Combined Spinal Epidural
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Sedation was more frequent in the meperidine group,
whereas hypotension was more common in the CSE and
epidural groups. Frequency of nausea, vomiting, shivering,
need for ephedrine use, and back pain were similar among
groups. The 1st- and 5th-min Apgar scores were similar
between the epidural, CSE, and meperidine groups (P =
0.97 and P = 0.23, respectively). Apgar scores in the 1st
and 5th min were not affected by the elapsed time between
meperidine administration and birth (0‒1 h, 1‒4 h, and >4
h). Six infants all of whom were delivered with epidural
analgesia (P = 0.047) were admitted to the neonatal
intensive care unit due to respiratory distress (n = 2), small
gestational age (n = 2), and unknown indication (n = 2).
4. Discussion
The pain of labor ranks consistently among the most severe
types of pain that a woman will experience during life.
From the expert’s point of view, the gold standard for pain
relief in labor is neuraxial analgesic techniques. However,
meperidine is still used as a standard of care in many clinics
and there are conflicting results in the literature regarding
the efficacy and safety of these methods. Considering
these conflicts and gap of knowledge within the literature,
reporting the results of the effects of epidural, combined
spinal epidural, and parenteral meperidine on mothers and
fetuses remain crucial. The present study has addressed
these controversies.
First, we discovered similar instrumental delivery rates
among groups. Cesarean delivery rates tended to be low in
the CSE group. Despite the high-quality analgesia and the
high maternal satisfaction, reservations remain regarding
the rate of instrumental delivery and cesarean section in
patients who were administered neuraxial analgesia [7–9].
In a metaanalysis involving 2400 patients, epidural analgesia
increased the duration of the first and second stages of
labor, unlike the risk of cesarean section [10]. Another
metaanalysis suggested similar instrumental delivery rates
between combined spinal–epidural and epidural analgesia
[7]. Both instrumental delivery and cesarean section
rates of neuraxial analgesia were reported to be lower
with diluted local anesthetics [19]. Although they could
not report a definite statement, a recent Cochrane review
indicated that an increased rate of instrumental delivery
was more likely to be related with less modern epidural
techniques [18]. In accordance with this result, we could
not identify any increase in instrumental delivery rates
with our technique, which may be considered modern,
considering the low concentration mixture of a local
anesthetic and opioid (0.0625% bupivacaine and fentanyl
2 μg/mL) that we used. Besides the techniques used, the
variable rates of instrumental and cesarean delivery could
also be explained by the experience of the center and the
history of the patient population.
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Second, we found that regional analgesic methods
did not affect the duration of the various labor stages in
the whole study population. However, subgroup analysis
revealed that the first stage of delivery was lengthened for
patients whose cervical dilatation was less than 4 cm at the
time of catheter insertion. In accordance with our findings,
studies have indicated that regional anesthesia that were
initiated when cervical dilatation was less than 4 cm
prolonged labor [20,21]. On the contrary, a randomized
controlled study showed that regional anesthesia had
no effect on labor durations, instrumental delivery, or
cesarean section rates, even when neuraxial intervention
was applied for under 2 cm of cervical dilatation [22].
Third, we found the decrease in the VAS values were
significantly higher in patients whose pain management
was done with epidural or CSE analgesia compared to
the meperidine group. These results are in agreement
with previous studies [23–25]. Indeed, our results are
noteworthy. We selected patients who expressed an
explicit desire not to have an epidural analgesia; in that
case, the prospect of access and knowledge to better care
could not bias results. Although patient satisfaction was
significantly lower in the meperidine group, it was better
than our expectations. This may be due to the sedation and
drowsiness caused by meperidine. In a metaanalysis from
2010 [15], it was shown that sedation and somnolence
were more frequent in patients who were on meperidine.
There was no difference among the groups in terms of the
1st- and 5th-min Apgar scores of the newborns of patients,
which is also consistent with the literature [7,24,26–28].
Fourth, we demonstrated that the administration time
of meperidine did not affect the fetal outcomes. It has been
shown that the peak plateau level of the fetal concentration
of meperidine appeared 1‒5 h after administration.
Although reports on the issue have been conducted, the
clinical significance of different administration times
have not been proven yet [15]. In our study, considering
meperidine pharmacokinetics [29], patients who
completed vaginal delivery were divided according to
elapsed time between the birth and the meperidine
administration (<1 h, 1‒4 h, and ≥4 h). First- and fifthminute Apgar scores were similar in these groups.
The neonatal ICU admission rates were higher in the
epidural group. This result was somewhat unexpected
since the neonatal intensive care admission rates are
known to be similar among the different analgesia groups
[27]. Selection bias might explain this since three of the
newborns were already scheduled for neonatal intensive
care follow-up before the initiation of labor. However, as
per the reported limitations of the recent Cochrane review
[18], it is important to report any kind of side effects that
may be associated with neuraxial analgesia.

BABAOĞLU et al. / Turk J Med Sci
Ours is one of the very few studies that have analyzed
the effects of all three techniques on the entire range of
outcomes related to the mother and fetus. However, the
retrospective nature of the neuraxial groups remained a
major limitation.
Our study sought to respond to the contradictions in
the literature and reported the efficacy and side effects of
each method meticulously. We demonstrated that regional
analgesia methods were reasonably safe for both mother

and fetus and that regional analgesia methods resulted in
greater maternal satisfaction and pain control compared to
meperidine. Extensive patient monitoring and accurately
chosen methods with appropriate dosing of local
anesthetics could minimize the side effects of neuraxial
methods.
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